Literature DB >> 19140168

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus.

Massimiliano Bianchi1, Ajit J Shah, Kevin C F Fone, Alan R Atkins, Lee A Dawson, Christian A Heidbreder, Mark E Hows, Jim J Hagan, Charles A Marsden.   

Abstract

A number of studies suggest that stressful conditions can induce structural alterations in the hippocampus and that antidepressant drugs may prevent such deficits. In particular, the selective serotonin reuptake inhibitor (SSRI) fluoxetine was more effective in modulating different neuronal plasticity phenomena and related molecules in rat hippocampus. Cytoskeletal microtubule dynamics are fundamental to dendrites and axons remodeling, leading to the hypothesis that fluoxetine may affect the microtubular system. However, despite reports of stress-induced alterations in microtubule dynamics by different stressors, only few studies investigated the in vivo effects of antidepressants on microtubules in specific rat brain regions. The present study investigated the dose-related (1, 5, or 10 mg/kg i.p.) effects of acute and chronic (21 days) treatments with fluoxetine on the ratio of hippocampal alpha-tubulin isoforms which is thought to reflect microtubule dynamics. Western Blot analysis was used to quantify alpha-tubulin isoforms, high-performance liquid chromatography and fluorescence detection was used to measure ex vivo monoamine metabolism. The results showed that acute fluoxetine increased the stable forms acetylated and detyrosinated alpha-tubulin. Conversely, chronic fluoxetine decreased acetylated alpha-tubulin, indicative of increased microtubule dynamics. The neuron-specific Delta2-Tubulin was increased by chronic fluoxetine indicating neuronal involvement in the observed cytoskeletal changes. Although acute and chronic fluoxetine similarly altered serotonin metabolism by inhibition of serotonin reuptake, this showed no apparent correlation to the cytoskeletal perturbations. Our findings demonstrate that fluoxetine administration modulates microtubule dynamics in rat hippocampus. The cytoskeletal effect exerted by fluoxetine may eventually culminate in promoting events of structural neuronal remodeling. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140168     DOI: 10.1002/syn.20614

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  A molecular and structural mechanism for G protein-mediated microtubule destabilization.

Authors:  Rahul H Davé; Witchuda Saengsawang; Manu Lopus; Sonya Davé; Leslie Wilson; Mark M Rasenick
Journal:  J Biol Chem       Date:  2010-11-26       Impact factor: 5.157

2.  3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.

Authors:  Massimiliano Bianchi; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

3.  Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex.

Authors:  David J G Watson; Florence Loiseau; Manuela Ingallinesi; Mark J Millan; Charles A Marsden; Kevin C F Fone
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.

Authors:  Lanqiu Zhang; Mark M Rasenick
Journal:  J Pharmacol Exp Ther       Date:  2009-12-08       Impact factor: 4.030

5.  Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds.

Authors:  Harinder Singh; Nathan Wray; Jeffrey M Schappi; Mark M Rasenick
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

6.  Consciousness, Cognition and the Neuronal Cytoskeleton - A New Paradigm Needed in Neuroscience.

Authors:  Stuart Hameroff
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

Review 7.  Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting.

Authors:  Isabella Barbiero; Massimiliano Bianchi; Charlotte Kilstrup-Nielsen
Journal:  J Neuroendocrinol       Date:  2021-09-08       Impact factor: 3.870

Review 8.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

9.  Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.

Authors:  Nataly Ladurelle; Cecilia Gabriel; Adela Viggiano; Elisabeth Mocaër; Etienne E Baulieu; Massimiliano Bianchi
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

Review 10.  Tubulin post-translational modifications control neuronal development and functions.

Authors:  Marie-Jo Moutin; Christophe Bosc; Leticia Peris; Annie Andrieux
Journal:  Dev Neurobiol       Date:  2020-08-29       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.